| Mon, Nov 16, 2009 | | • | Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium
GlobeNewswire (Mon, Nov 16)
| | • | Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
GlobeNewswire (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | AASTROM BIOSCIENCES INC Financials
EDGAR Online Financials (Fri, Nov 13)
| | • | Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com
GlobeNewswire (Fri, Nov 13)
| | Wed, Nov 11, 2009 | | • | Can Stem Cells Put an End To Paralysis?
Indie Research (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
GlobeNewswire (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | • | Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready?
Wall Street Transcript (Mon, Nov 9)
| | Fri, Nov 6, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Nov 6)
| | • | Aastrom Biosciences Reports First Quarter Fiscal Year 2010 Financial Results
GlobeNewswire (Fri, Nov 6)
| | Fri, Oct 30, 2009 | | • | Stem Cell Traders Flock to Geron
Indie Research (Fri, Oct 30)
| | • | Integrity Media: Stem Cell Report Released
GlobeNewswire (Fri, Oct 30)
| | Tue, Oct 27, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
EDGAR Online (Tue, Oct 27)
| | Tue, Oct 20, 2009 | | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
EDGAR Online (Tue, Oct 20)
| | • | Harold C. Urschel, Jr., M.D. Joins Aastrom Biosciences' Board of Directors
GlobeNewswire (Tue, Oct 20)
| | Fri, Oct 9, 2009 | | • | Another Coin-Flip Bet on a Stem Cell Drug
Indie Research (Fri, Oct 9)
| | Wed, Oct 7, 2009 | | • | Aastrom Biosciences receives delisting notice
AP (Wed, Oct 7)
| | • | AASTROM BIOSCIENCES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta
EDGAR Online (Wed, Oct 7)
| | • | Aastrom Receives Letter From NASDAQ Regarding Continued Non-Compliance With Minimum Bid Price Rule
GlobeNewswire (Wed, Oct 7)
| | Wed, Sep 30, 2009 | | • | Stem Cell Summit Can't Excite Investors
Indie Research (Wed, Sep 30)
| | Thu, Sep 24, 2009 | | • | Aastrom Biosciences to Present At Maxim Group Growth Conference
GlobeNewswire (Thu, Sep 24)
|
Add ASTM News to My Yahoo!:
 
| |
|
1.48% Nasdaq 
Headlines
